Press Releases

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services. This includes the opening of a new Screening and Return Center, upgraded pharmacy compounding suites, expanded Absorption, Distribution,...

Novartis announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids to use in potential gene therapies for neurological diseases, with options to access capsids for two...

Vibalogics, a leading virotherapy contract development and manufacturing organization (CDMO) focused on the production of live– viruses and viral vectors, has announced the completion of its expansion project at its GMP facility in Cuxhaven, Germany. The new building features biosafety...

Thermo Fisher Scientific Inc., the world leader in serving science, enables analytical testing laboratories across a variety of sectors, including food, environmental, industrial and pharma to now meet their ever-increasing efficiency and productivity needs with a collection of new...

Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a partnership with WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry. Orbit will combine...

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), won the 2022 CMO Leadership Awards in all six core categories – quality, expertise, compatibility, capabilities, reliability and service. Vetter also achieved Champion status in the areas of quality,...

Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced a manufacturing partnership that will advance Ray Therapeutics’ lead optogenetics gene therapy...